Zydus Wellness Share News - Latest Updates, Live News & More

Latest news about Zydus Wellness

Zydus Wellness Poised for Growth as Key Brands See GST Rate Cut to 5% 6 days ago

Zydus Wellness announced that several of its key brands, including Complan, Glucon-D, Nutralite, Nycil, RiteBite Max Protein, and SugarFree, will now be subject to a reduced GST rate of 5%. The company expects this change to enhance product affordability, stimulate demand, and strengthen its market position. Zydus Wellness believes these tax reforms will positively impact its performance in the FMCG sector.

Zydus Wellness Unit Acquires UK's Comfort Click for £239 Million 10 days ago

Zydus Wellness Expands Global Footprint with £239 Million Acquisition of UK's Comfort Click Aug 29, 2025

Zydus Wellness CEO Optimistic About Demand Growth, Company Receives Improved ESG Rating Aug 22, 2025

Zydus Wellness Announces 5-for-1 Stock Split, Sets September 18, 2025 as Record Date Aug 18, 2025

More news about Zydus Wellness

05Aug 25

Zydus Wellness Expands Global Footprint with UK Subsidiary, Reports Resilient Q1 Performance

Zydus Wellness Limited established a new UK subsidiary, Alidac UK Limited, to focus on FMCG investment and trading. The company reported Q1 FY2024 results with 2.2% growth in consolidated net sales to Rs. 8,577.00 million, despite challenges from early monsoons. EBITDA increased marginally by 0.2%, while PAT declined by 13.4%. The personal care segment grew by 3.8%, while the food and nutrition segment saw subdued growth of 1.6%. Zydus Wellness expanded its product portfolio and maintained strong market positions across brands. The company aims to expand its direct reach to 700,000 outlets by the end of the financial year.

05Aug 25

Zydus Wellness Navigates Seasonal Challenges, Reports 2.2% Growth in Q1

Zydus Wellness Limited posted consolidated net sales growth of 2.2% in Q1, reaching Rs. 8,577.00 million. Early monsoons impacted seasonal brands, but non-seasonal products showed strong double-digit growth. Personal care segment grew 3.8% year-on-year, while food and nutrition segment grew 1.6%. EBITDA increased by 0.2% to Rs. 1,556.00 million, but PAT declined 13.4%. The company maintained market leadership in key categories and plans to expand distribution reach to 7 lakh outlets by fiscal year-end. Zydus Wellness also established a UK subsidiary to strengthen its global FMCG presence.

05Aug 25

Zydus Wellness Navigates Seasonal Challenges, Reports 2.2% Revenue Growth in Q1

Zydus Wellness achieved a 2.2% growth in consolidated net sales to Rs. 8,577.00 million in Q1, despite early monsoon impacts on seasonal brands. The company's non-seasonal portfolio showed strong double-digit growth, offsetting challenges faced by seasonal brands like Nycil and Glucon D. Personal care segment grew by 3.8% year-on-year, while food and nutrition segment growth was subdued at 1.6%. EBITDA marginally increased by 0.2% to Rs. 1,556.00 million, but PAT declined by 13.4%. The company maintained market leadership across key brands and improved organized trade saliency to 30.9%. E-commerce contributed 14.5% to overall sales. Zydus Wellness remains focused on margin resilience, tech-enabled efficiencies, and sustainable growth through innovation and expansion.

30Jul 25

Zydus Wellness Shareholders Approve 1:5 Stock Split and Report Strong Q1 Performance

Zydus Wellness held its 31st AGM on July 30, 2025, approving a 1:5 stock split and releasing Q1 FY2026 results. Shareholders approved splitting each ₹10 face value share into five ₹2 shares. Q1 saw consolidated net sales of ₹8,577.00 million, up 2.2% YoY, with net profit at ₹1,279.00 million. The company maintained market leadership in key categories and reported growth in e-commerce and modern trade channels. Other developments include re-appointment of auditors, international business expansion plans, and product portfolio growth.

30Jul 25

Zydus Wellness Reports Mixed Q1 Results; Supreme Court Dismisses SLP Against Subsidiary

Zydus Wellness announced mixed Q1 financial results with a 13% decrease in net profit to ₹1.28 billion, despite a 2.3% increase in revenue to ₹8.58 billion. EBITDA slightly improved to ₹1.56 billion, but the margin compressed to 18.10%. In a separate development, the Supreme Court dismissed a Special Leave Petition against Zydus Wellness Products Limited, the company's wholly-owned subsidiary, regarding budgetary support under the GST regime.

29Jul 25

Supreme Court Dismisses Special Leave Petition Against Zydus Wellness Subsidiary

The Supreme Court of India dismissed a Special Leave Petition filed by the Union of India against Zydus Wellness Products Limited (ZWPL), a wholly owned subsidiary of Zydus Wellness Limited. This ruling upholds a previous Sikkim High Court order favoring ZWPL in a case regarding the denial of budgetary support under the GST regime following the company's conversion from a partnership firm to a company. The dismissal potentially secures ZWPL's right to receive budgetary support under a scheme introduced by the Department of Industrial Policy and Promotion in 2017.

04Jul 25

Zydus Wellness Faces Supreme Court Challenge in Budgetary Support Case

Zydus Wellness is involved in a Supreme Court case regarding an undisclosed budgetary support issue. The company expresses confidence in its legal position despite the ongoing challenge. The case's outcome could significantly impact Zydus Wellness's financial planning and budgetary allocations, attracting close attention from investors and market observers.

17Jun 25

Zydus Wellness Shares Surge on Major Block Deal and Strong Q4 Performance

Zydus Wellness executed a block deal worth ₹879.00 crore, involving 7.3% of its equity. The company reported a 15% increase in Q4 net profit, with revenue rising 16.55% to ₹911.40 crore. EBITDA grew 16.52% to ₹188.30 crore, and EPS improved by 14.35% to ₹27.01. The board approved a 1:5 stock split and declared a dividend of ₹6.00 per share.

21May 25

Zydus Wellness Unveils New Brand Identity Amidst Robust Financial Performance

Zydus Wellness has announced a major rebranding initiative, adopting a modern teal and purple color palette to reflect its focus on scientific innovation and digital wellness. Concurrently, the company reported impressive financial results for the year. Consolidated net sales increased by 16.2% to ₹2,691.20 crore, while net profit surged 30% to ₹341.00 crore. EBITDA also saw significant growth, rising 23.2% to ₹379.70 crore. This combination of rebranding and strong financial performance signals Zydus Wellness' strategic shift towards modernization and its ability to adapt to evolving consumer health trends.

21May 25

Zydus Wellness Sets Sights on Early-Teens Revenue Growth for FY26

Zydus Wellness reported 16% revenue growth in FY25 and aims for early-teens growth in FY26. The company targets margin expansion to 17-18% over the next couple of years. Personal care segment expected to outperform food and nutrition. Max Protein brand, acquired by Zydus, projected to maintain 25-30% growth rate.

19May 25

Zydus Wellness Announces 1:5 Stock Split, Dividend, and Strong Q4 Results

Zydus Wellness has approved a 1:5 stock split, reducing share face value from ₹10 to ₹2, and declared a ₹6 per share dividend. The company reported a 14.70% increase in Q4 net profit to ₹172 crore and 16.70% revenue growth. These decisions aim to enhance liquidity and broaden the investor base. The stock split and dividend are subject to shareholder approval at the July 30, 2025 AGM.

19May 25

Zydus Wellness Reports Strong Performance with 30% Profit Growth

Zydus Wellness announced strong financial results with a 30% increase in net profit to ₹341.00 crore and 16.2% growth in net sales to ₹2,691.20 crore. The company's quarterly performance showed 17% year-over-year revenue growth to ₹910.60 crore, with EBITDA rising 17.30% to ₹190.00 crore. The EBITDA margin slightly improved to 20.81%. Zydus Wellness declared a dividend of ₹6.00 per share, demonstrating its commitment to shareholder value.

09May 25

Zydus Wellness to Deliberate Q4 Results and Potential Share Split on May 19

Zydus Wellness has scheduled a board meeting for May 19 to review Q4 financial results and discuss a possible share split. The potential split could increase stock liquidity and broaden investor access. The meeting's outcome is anticipated to impact the company's market positioning and shareholder value in the competitive consumer goods sector.